These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25208639)

  • 1. Performance of LigAmp assay for sensitive detection of drug-resistant hepatitis B virus minor variants in comparison with standard nucleotide sequencing.
    Ismail AM; Sachithanandham J; Eapen CE; Kannangai R; Abraham P
    Mol Diagn Ther; 2014 Dec; 18(6):655-63. PubMed ID: 25208639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid detection of hepatitis B virus variants associated with lamivudine and adefovir resistance by multiplex ligation-dependent probe amplification combined with real-time PCR.
    Jia S; Wang F; Li F; Chang K; Yang S; Zhang K; Jiang W; Shang Y; Deng S; Chen M
    J Clin Microbiol; 2014 Feb; 52(2):460-6. PubMed ID: 24478474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of real time allele specific locked nucleic acid quantitative PCR for detection of HBV YIDD (ATT) mutation and evaluation of its application.
    Zeng Y; Li D; Wang W; Su M; Lin J; Chen H; Jiang L; Chen J; Yang B; Ou Q
    PLoS One; 2014; 9(2):e90029. PubMed ID: 24587198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of peptide nucleic acid mediated polymerase chain reaction clamping (PMPC)--direct sequencing method for detecting lamivudine-resistant hepatitis B virus (HBV) variants with high sensitivity and specificity.
    Ogata N; Ichida T; Aoyagi Y; Kitajima I
    Rinsho Byori; 2003 Apr; 51(4):313-9. PubMed ID: 12747252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
    Enomoto M; Tamori A; Kohmoto MT; Morikawa H; Habu D; Sakaguchi H; Takeda T; Seki S; Kawada N; Shiomi S; Nishiguchi S
    J Med Virol; 2007 Nov; 79(11):1664-70. PubMed ID: 17854034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B.
    Coppola N; Tonziello G; Colombatto P; Pisaturo M; Messina V; Moriconi F; Alessio L; Sagnelli C; Cavallone D; Brunetto M; Sagnelli E
    J Infect; 2013 Oct; 67(4):322-8. PubMed ID: 23796869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation into drug-resistant mutations of HBV from 845 nucleoside/nucleotide analogue-naive Chinese patients with chronic HBV infection.
    Li X; Liu Y; Zhao P; Wang Y; Chen L; Xin S; Zhang XX; Xu D
    Antivir Ther; 2015; 20(2):141-7. PubMed ID: 24992206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy.
    Lee YS; Chung YH; Kim JA; Kim SE; Shin JW; Kim KM; Lim YS; Park NH; Lee HC; Lee YS; Suh DJ
    Liver Int; 2009 Apr; 29(4):552-6. PubMed ID: 19323782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B.
    Cha CK; Kwon HC; Cheong JY; Cho SW; Hong SP; Kim SO; Yoo WD
    J Med Virol; 2009 Mar; 81(3):417-24. PubMed ID: 19152409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBV/4DR 9G test and its comparison with INNO-LiPA HBV multi-DR test for the detection of drug-resistant Hepatitis B virus.
    Chantratita W; Song KS; Pongthanapisith V; Thongbaiphet N; Angkanavin K; Nimse SB; Sonawane MD; Kim T
    J Virol Methods; 2016 Nov; 237():58-63. PubMed ID: 27581951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy.
    Mirandola S; Sebastiani G; Rossi C; Velo E; Erne EM; Vario A; Tempesta D; Romualdi C; Campagnolo D; Alberti A
    Antiviral Res; 2012 Dec; 96(3):422-9. PubMed ID: 23026293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of hepatitis B virus resistance mutations against nucleoside/nucleotide analogue treatment in Chinese patients with chronic hepatitis B.
    Lei J; Wang Y; Wang LL; Zhang SJ; Chen W; Bai ZG; Xu LY
    Virol J; 2013 Oct; 10():313. PubMed ID: 24160943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. rtM204Q may serve as a novel lamivudine-resistance-associated mutation of hepatitis B virus.
    Liu Y; Xu Z; Wang Y; Li X; Liu L; Chen L; Xin S; Xu D
    PLoS One; 2014; 9(2):e89015. PubMed ID: 24586482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution of hepatitis B virus quasispecies during antiviral therapy in one chronic hepatitis B patient].
    Liang PP; Guo JJ; Li QL; Luo Q; Shi XF; Huang AL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):516-20. PubMed ID: 22152243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasensitive amplification refractory mutation system real-time PCR (ARMS RT-PCR) assay for detection of minority hepatitis B virus-resistant strains in the era of personalized medicine.
    Ntziora F; Paraskevis D; Haida C; Manesis E; Papatheodoridis G; Manolakopoulos S; Elefsiniotis I; Karamitros T; Vassilakis A; Hatzakis A
    J Clin Microbiol; 2013 Sep; 51(9):2893-900. PubMed ID: 23804383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside/nucleotide analogue treatment among Chinese chronic hepatitis B patients.
    Yang JX; Liu BM; Li XG; Yan CH; Xu J; Sun XW; Wang YH; Jiao XJ; Yan L; Dong JP; Hou CS; Abuduheilili X; Li T; Zhuang H
    Antivir Ther; 2010; 15(8):1171-8. PubMed ID: 21149924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of lamivudine-resistant variants and mutations related to reduced antigenicity of HBsAg in individuals from the cities of Santos and São Paulo, Brazil.
    Mantovani N; Cicero M; Santana LC; Silveira C; do Carmo EP; Abrão PR; Diaz RS; Caseiro MM; Komninakis SV
    Virol J; 2013 Oct; 10():320. PubMed ID: 24165277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hepatitis B infection associated with drug-resistant hepatitis B virus.
    Xu Z; Liu Y; Xu T; Chen L; Si L; Wang Y; Ren X; Zhong Y; Zhao J; Xu D
    J Clin Virol; 2010 Aug; 48(4):270-4. PubMed ID: 20580309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenofovir is a more suitable treatment than entecavir for chronic hepatitis B patients carrying naturally occurring rtM204I mutations.
    Choe WH; Kim K; Lee SY; Choi YM; Kwon SY; Kim JH; Kim BJ
    World J Gastroenterol; 2019 Sep; 25(33):4985-4998. PubMed ID: 31543688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of allele-specific detection techniques to quantify minority resistance variants in hepatitis B infection: a novel approach.
    Bhattacharya D; Lewis MJ; Lassmann B; Phan T; Knecht G; Bickel M; Yang OO
    J Virol Methods; 2013 Jun; 190(1-2):34-40. PubMed ID: 23454647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.